Literature DB >> 21135133

Cooperative signaling between Slit2 and Ephrin-A1 regulates a balance between angiogenesis and angiostasis.

Charlene M Dunaway1, Yoonha Hwang, Craig W Lindsley, Rebecca S Cook, Jane Y Wu, Mark Boothby, Jin Chen, Dana M Brantley-Sieders.   

Abstract

Slit proteins induce cytoskeletal remodeling through interaction with roundabout (Robo) receptors, regulating migration of neurons and nonneuronal cells, including leukocytes, tumor cells, and endothelium. The role of Slit2 in vascular remodeling, however, remains controversial, with reports of both pro- and antiangiogenic activity. We report here that cooperation between Slit2 and ephrin-A1 regulates a balance between the pro- and antiangiogenic functions of Slit2. While Slit2 promotes angiogenesis in culture and in vivo as a single agent, Slit2 potently inhibits angiogenic remodeling in the presence of ephrin-A1. Slit2 stimulates angiogenesis through mTORC2-dependent activation of Akt and Rac GTPase, the activities of which are inhibited in the presence of ephrin-A1. Activated Rac or Akt partially rescues vascular assembly and motility in costimulated endothelium. Taken together, these data suggest that Slit2 differentially regulates angiogenesis in the context of ephrin-A1, providing a plausible mechanism for the pro- versus antiangiogenic functions of Slit2. Our results suggest that the complex roles of Slit-Robo signaling in angiogenesis involve context-dependent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21135133      PMCID: PMC3028625          DOI: 10.1128/MCB.00667-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  77 in total

1.  A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein.

Authors:  L B Holzman; R M Marks; V M Dixit
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Characterization of B61, the ligand for the Eck receptor protein-tyrosine kinase.

Authors:  H Shao; A Pandey; K S O'Shea; M Seldin; V M Dixit
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

3.  B61 is a ligand for the ECK receptor protein-tyrosine kinase.

Authors:  T D Bartley; R W Hunt; A A Welcher; W J Boyle; V P Parker; R A Lindberg; H S Lu; A M Colombero; R L Elliott; B A Guthrie
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

4.  Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse.

Authors:  P S Jat; M D Noble; P Ataliotis; Y Tanaka; N Yannoutsos; L Larsen; D Kioussis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors.

Authors:  Nikki Cheng; Dana Brantley; Wei Bin Fang; Hua Liu; William Fanslow; Douglas Pat Cerretti; Katrin N Bussell; Alastair Reith; Dowdy Jackson; Jin Chen
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

6.  EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.

Authors:  Dana M Brantley-Sieders; Justin Caughron; Donna Hicks; Ambra Pozzi; Joseph C Ruiz; Jin Chen
Journal:  J Cell Sci       Date:  2004-03-30       Impact factor: 5.285

7.  Vilse, a conserved Rac/Cdc42 GAP mediating Robo repulsion in tracheal cells and axons.

Authors:  Annika Lundström; Marco Gallio; Camilla Englund; Pär Steneberg; Johanna Hemphälä; Pontus Aspenström; Krystyna Keleman; Ludmilla Falileeva; Barry J Dickson; Christos Samakovlis
Journal:  Genes Dev       Date:  2004-09-01       Impact factor: 11.361

8.  Conserved roles for Slit and Robo proteins in midline commissural axon guidance.

Authors:  Hua Long; Christelle Sabatier; Le Ma; Andrew Plump; Wenlin Yuan; David M Ornitz; Atsushi Tamada; Fujio Murakami; Corey S Goodman; Marc Tessier-Lavigne
Journal:  Neuron       Date:  2004-04-22       Impact factor: 17.173

9.  Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist.

Authors:  Pawel Dobrzanski; Kathryn Hunter; Susan Jones-Bolin; Hong Chang; Candy Robinson; Sonya Pritchard; Hugh Zhao; Bruce Ruggeri
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

Review 10.  Eph receptor tyrosine kinases in angiogenesis: from development to disease.

Authors:  Dana M Brantley-Sieders; Jin Chen
Journal:  Angiogenesis       Date:  2004       Impact factor: 9.596

View more
  19 in total

1.  Slit2 overexpression results in increased microvessel density and lesion size in mice with induced endometriosis.

Authors:  Sun-Wei Guo; Yu Zheng; Yuan Lu; Xishi Liu; Jian-Guo Geng
Journal:  Reprod Sci       Date:  2012-08-08       Impact factor: 3.060

Review 2.  Mechanisms of endothelial cell migration.

Authors:  U Ruth Michaelis
Journal:  Cell Mol Life Sci       Date:  2014-07-20       Impact factor: 9.261

3.  CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators.

Authors:  Liya Pi; Anitha K Shenoy; Jianwen Liu; Seungbum Kim; Nikole Nelson; Huiming Xia; William W Hauswirth; Bryon E Petersen; Gregory S Schultz; Edward W Scott
Journal:  FASEB J       Date:  2012-05-18       Impact factor: 5.191

Review 4.  Ephs and ephrins in cancer: ephrin-A1 signalling.

Authors:  Amanda Beauchamp; Waldemar Debinski
Journal:  Semin Cell Dev Biol       Date:  2011-10-25       Impact factor: 7.727

5.  EphrinA1 is released in three forms from cancer cells by matrix metalloproteases.

Authors:  Amanda Beauchamp; Mark O Lively; Akiva Mintz; Denise Gibo; Jill Wykosky; Waldemar Debinski
Journal:  Mol Cell Biol       Date:  2012-06-11       Impact factor: 4.272

Review 6.  Robo4-dependent Slit signaling stabilizes the vasculature during pathologic angiogenesis and cytokine storm.

Authors:  Nyall R London; Dean Y Li
Journal:  Curr Opin Hematol       Date:  2011-05       Impact factor: 3.284

7.  Molecular mechanisms of tumor angiogenesis.

Authors:  Safiyyah Ziyad; M Luisa Iruela-Arispe
Journal:  Genes Cancer       Date:  2011-12

8.  Ephrin-Eph signaling as a potential therapeutic target for the treatment of myocardial infarction.

Authors:  Wesley T O'Neal; William F Griffin; Jessica L Dries-Devlin; Susan D Kent; Jin Chen; Monte S Willis; Jitka A I Virag
Journal:  Med Hypotheses       Date:  2013-04-04       Impact factor: 1.538

Review 9.  A roundabout way to cancer.

Authors:  Mimmi S Ballard; Lindsay Hinck
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

10.  Progranulin/EphA2 axis: A novel oncogenic mechanism in bladder cancer.

Authors:  Simone Buraschi; Thomas Neill; Shi-Qiong Xu; Chiara Palladino; Antonino Belfiore; Renato V Iozzo; Andrea Morrione
Journal:  Matrix Biol       Date:  2020-05-15       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.